rss
Br J Ophthalmol 84:979-982 doi:10.1136/bjo.84.9.979
  • Original Article
    • Clinical science

Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome

Table 3

Side effects of cyclosporin

Case Malaise Cramps Mg Incr BP Other Creat incr Final creat
(μmol/l)
1 N N 1.25 N N N 82
2 N N NA N N N 97
3 N N 0.74 N I Y–2 months 77
4 Y N 0.85 N G, L Y–single test 80
5 N N 0.78 N N Y–1 year 106
6 Y N 0.71 N N Y–2 months 93
7 N N 0.83 N N N 92
  • Malaise = any recorded systemic symptom (tiredness, fatigue, nausea, vomiting, temperature intolerance) recorded in case notes, regardless of whether this necessitated change in treatment. Cramps = any muscle cramps recorded in case notes. Incr BP = rise in blood pressure sufficient to require change in treatment. Other = any other adverse effects recorded in case notes, regardless of whether this necessitated change in treatment: I = secondary infection (infectious keratitis), G = gingival hyperplasia, L = lymphopenia (transient in this case). Creat incr = raised level of plasma creatinine above 120 μmol/l; N = nil, Y = yes with duration specified.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.